Evidence map›Paper›PMID 36895415›Full record

ArticleCurrent research in structural biology2023

Identification and prioritization of potential therapeutic molecules against LpxA from

Rameez Jabeer Khan, Ekampreet Singh, Rajat Kumar Jha, Ankit Kumar, Saurabh Kumar Bhati, Mahrukh Parveez Zia, Monika Jain, Rashmi Prabha Singh, Jayaraman Muthukumaran, Amit Kumar Singh

Open access · goldAbstract read
In one paragraph

Article in Current research in structural biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Antibacterial carbon dots.Materials today. Bio · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rameez Jabeer KhanDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Ekampreet SinghDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Rajat Kumar JhaDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Ankit KumarDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Saurabh Kumar BhatiDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Mahrukh Parveez ZiaDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Monika JainDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Rashmi Prabha SinghDepartment of Biotechnology, IILM College of Engineering & Technology, Greater Noida, U.P, India.
Jayaraman MuthukumaranDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Amit Kumar SinghDepartment of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P, India.
Sharda University · INIILM Institute for Higher Education · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A. baumannii is a ubiquitously found gram-negative, multi-drug resistant bacterial species from the ESKAPE family of pathogens known to be the causative agent for hospital-acquired infections such as pneumonia, meningitis, endocarditis, septicaemia and urinary tract infections.

Indexed as

Free energy landscapeGlobal and essential dynamicsLpxAMM/PBSAMolecular dynamics simulations

Identifiers

PMID36895415
PMCPMC9988473
OpenAlexW4320912423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.